Another Reason to Argue About Prostate-Cancer Screening
Screening: The US Preventive Services Task Force has recommended that doctors stop routinely testing men for the prostate specific antigen because harmful surgeries spurred by false alarms outweigh the potential to save lives. The American Urological Association is "outraged," reports Richard Knox for NPR.
Transparency: Eight pharmaceutical companies have approved a set of new transparency guidelines in an attempt to repair the reputation of industry-funded science. If companies stick to the protocol, it will mean that they will make the results of all clinical trials public, and reveal whether scientists were paid to put their names on papers ghostwritten by the industry, reports Kevin B. O'Reilly for American Medical News.
Health Claims: A judge has issued a cease and desist order to Pom Wonderful barring the company from making misleading claims about the benefits of its pomegranate juice for the next 20 years, reports Stephanie Strom for the New York Times.
Medical Costs: Companies have found they can save money by giving their workers unlimited free access to primary care doctors, a model called "concierge care" when used by the rich, reports Bruce Japsen for the New York Times.
Fake Drugs: Counterfeit malaria pills are threatening lives in Asia and Africa, and breeding a drug-resistance into the disease, reports Kate Kelland for Reuters.
Photo credit: Melanie Haiken via Flickr